Analyzing matched samples collected longitudinally during disease course, we found that a subgroup of ovarian cancer patients relapsed after platinum-based chemotherapy are characterized by decreased intratumor PHGDH levels, and that the extent of such decrease correlates with worse prognosis. The gene discussed is PHGDH; the disease is ovarian cancer.